首页> 外文期刊>Archives of medical research >10?years Analysis of Diabetes-related Major Lower Extremity Amputations in Mexico
【24h】

10?years Analysis of Diabetes-related Major Lower Extremity Amputations in Mexico

机译:10?多年分析糖尿病相关的主要下肢截肢

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundLittle is known about diabetes-related major lower extremity amputations (DMLEA) burden in México. Aim of the StudyTo describe DMLEA hospitalization rates, in-hospital survival rates, characteristics associated with all-cause in-hospital mortality and direct costs of hospitalization during the 2005–2015 period, in the two principal Health Institutions in Mexico: the Mexican Institute of Social Security (IMSS) and the Ministry of Health (MoH). MethodsA secondary data analysis was conducted using hospital discharge information obtained from administrative databases. Non-traumatic DMLEA hospitalizations in adults aged 20?years and over were analyzed. Hospitalization characteristics and in-hospital all-cause mortality risk were also assessed. Direct costs of hospitalization including length of hospital stay, surgical procedure, wound care and medical emergency consultation were accounted in U.S. dollars (USD, 2015). ResultsThere were 34,051 DMLEA hospitalizations and 1,268 in-hospital deaths. DMLEA hospitalizations rates increase from 4.71–6.12 × 100,000 affiliates during 2005 and 2015 respectively for both institutions together. Females and age ≥60?years were associated with all-cause in-hospital death. The all-period direct costs of hospitalization amounted to $132.51 million USD ($86.30 in the IMSS and $46.21 in the MoH), and showed a sustained increment: from $4.14 million USD in 2005 to $24.84 million USD in 2015 (percentage increase 499.3%). ConclusionsIn-hospital mortality was 3.7%. Female sex and age ≥60?years were characteristics associated with all-cause in-hospital death. The increase in the number of DMLEA hospitalizations and their direct costs, reflects a negative progression of diabetes in the two largest Health Institutions in Mexico.
机译:BrucktyLittle是关于乳糖相关的主要下肢截肢(DMLEA)负担的令人着称。研究的目的描述DMLEA住院率,住院存活率,与全因医院死亡率和2005 - 2015年期间的直接成本,在2005 - 2015年期间的直接费用,在墨西哥的两家主要卫生机构:墨西哥学院社会保障(IMSS)和卫生部(MOH)。方法使用从管理数据库获得的医院放电信息进行二次数据分析。分析了20岁的成年人的非创伤性DMLEA住院治疗。还评估了住院特征和住院内的全因死亡率风险。住院的直接费用包括住院住院时间,外科手术,伤口护理和医疗紧急咨询的长度均占美国美元(2015年USD)。结果是34,051个DMLEA住院治疗和1,268名医院死亡。 DMLEA住院时间分别从2005年和2015年的4.71-6.12×100,000个附属公司分别为两个机构共同增加。女性和年龄≥60?岁月与医院内部死亡有关。住院的全期直接费用为132.51亿美元(IMSS 86.30美元,MOH $ 46.21),并持续增量:2015年的4140万美元至24840万美元(百分比增长499.3%)。结论 - 医院死亡率为3.7%。女性和年龄≥60?多年是与医院内部死亡有关的特征。 DMLEA住院治疗数量及其直接成本的增加反映了墨西哥两大卫生机构糖尿病的负面进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号